WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012110886) CONTROLLED-RELEASE FORMULATION COMPRISING HCG
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/110886    International Application No.:    PCT/IB2012/000272
Publication Date: 23.08.2012 International Filing Date: 16.02.2012
IPC:
A61K 9/19 (2006.01), A61K 9/50 (2006.01), A61K 38/24 (2006.01), A61K 9/00 (2006.01)
Applicants: SANZYME LIMITED [IN/IN]; 8-2-120/13/5 Plot No. 13, Sagar Society, Road No. 2 Banjara Hills 500034 Hyderabad (IN) (For All Designated States Except US).
PRASAD, Kompella Venkata Subrahmanya [IN/IN]; (IN) (For US Only).
SOMAN, Jay Laxman [IN/IN]; (IN) (For US Only).
VAVIA, Pradeep Ratilal [IN/IN]; (IN) (For US Only).
VORA, Lalitkumar Khimjibhai [IN/IN]; (IN) (For US Only)
Inventors: PRASAD, Kompella Venkata Subrahmanya; (IN).
SOMAN, Jay Laxman; (IN).
VAVIA, Pradeep Ratilal; (IN).
VORA, Lalitkumar Khimjibhai; (IN)
Agent: GOPAKUMAR NAIR ASSOCIATES; 3rd Floor, 'Shivmangal', Near Big Bazaar Akurli Road, Kandivali (East) Mumbai 400 101 Maharashtra (IN)
Priority Data:
2298/MUM/2010 16.02.2011 IN
Title (EN) CONTROLLED-RELEASE FORMULATION COMPRISING HCG
(FR) FORMULATION À LIBÉRATION CONTRÔLÉE COMPRENANT HCG
Abstract: front page image
(EN)A controlled-release formulation comprising human chorionic gonadotropin (hCG) or hCG variants, a process of preparation of thereof and use of the formulation are provided herein. The formulation as disclosed in the present invention avoids the need for repeated injections.
(FR)La présente invention concerne une formulation à libération contrôlée comprenant de la gonadotrophine chorionique humaine (hCG) ou des variants de hCG, un procédé de préparation de celle-ci et l'utilisation de la formulation. La formulation telle que décrite dans la présente invention évite la nécessité d'injections répétées.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)